Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Risk governance (RG) of nanomaterials (NMs) has been at the focus of the Horizon 2020 Programme of the European Union, through the funding of three research projects (Gov4Nano, NANORIGO, RISKGONE). The extensive collaboration of the three projects, in various scientific topics, aimed to enhance RG of NMs and provide a solid scientific basis for effective collaboration of the various types of stakeholders involved. In this paper the development of a digital Nano Risk Governance Portal (NRGP) and associated information technology (IT) infrastructure supporting the risk governance of (engineered) nanomaterials and nano-enabled products, is presented, alongside considerations for future work and enhancement within the domain of Advanced Materials (AdMa). This paper describes several elements of this digital portal, which serves as a single-entry point for all stakeholders in need of, or interested in, nano-risk governance aspects. In its simplest form, the NRGP allows users to be efficiently guided towards tailored information about nanomaterials, risk governance concepts, guidance documents, harmonized methods for risk assessment, publicly accessible data, information and knowledge, as well as a directory of tools, to assess the exposure and hazard of nanomaterials and perform Safe-and-Sustainable-by-Design (SSbD) assessment in the context of nano-risk governance. This paper presents the technical implementation and the content of the first version of the NRGP alongside the vision for the future and further plans for development, implementation, hosting and maintenance of the NRGP aimed at ensuring its sustainability. This includes a procedure to link to, or include, currently available and future (nano)material-related (cloud) platforms, decision support systems, tools, guidance, and databases in line with good governance objectives.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12213299 | PMC |
| http://dx.doi.org/10.1016/j.csbj.2025.06.024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Resilience in the Face of Uncertainty: Navigating Supply Chain Challenges Through Proactive Risk Surveillance and Mitigation Strategies among SMEs in ASEAN countries.
F1000Res
September 2025
Department of Business Administration, World University of Bangladesh, Dhaka, 1230, Bangladesh.
Supply chain risk management is crucial for the consumer products industry, given its susceptibility to uncertainties and risks. This research investigates the relationship between supply chain risks and performance within this sector, based on a sample of 385 entrepreneurs from Small Medium Sized enterprises (SMEs) in the consumer goods industry across ASEAN countries. Supply chain performance, defined as the ability to meet end-customer demands, involves ensuring commodity availability, on-time deliveries, and maintaining sufficient inventory and capacity across organizational boundaries, from raw materials to the final consumer.
View Article and Find Full Text PDFA genome-wide association study identifies new loci associated with response to SARS-CoV-2 mRNA-1273 vaccine in a cohort of healthy healthcare workers.
Front Immunol
September 2025
Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Parque Tecnológico de Ciencias de la Salud (PTS), Granada, Spain.
Introduction: The COVID-19 pandemic had significant global public health consequences, affecting over 200 countries and regions by 2020. The development and efficacy of specific vaccines, such as the mRNA-1273 (Spikevax) vaccine developed by Moderna Inc., have substantially reduced the impact of the pandemic and mitigated its consequences.
View Article and Find Full Text PDFExplainable Machine Learning Assists in Revealing Associations Between Polysomnographic Biomarkers and Incident Type 2 Diabetes in Men.
Nat Sci Sleep
August 2025
Flinders Health and Medical Research Institute-- Sleep Health (Adelaide Institute for Sleep Health), College of Medicine and Public Health, Flinders University, Bedford Park, SA, 5042, Australia.
Introduction: Type 2 diabetes (T2D) shows bidirectional relationships with polysomnographic measures. However, no studies have searched systematically for novel polysomnographic biomarkers of T2D. We therefore investigated if state-of-the-art explainable machine learning (ML) models could identify new polysomnographic biomarkers predictive of incident T2D.
View Article and Find Full Text PDFSuprathreshold dosing of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: A case series.
Indian J Psychiatry
August 2025
Department of Psychiatry, Institute of Psychiatry-Centre of Excellence, Kolkata, West Bengal, India.
Supratherapeutic dosing of selective serotonin reuptake inhibitors (SSRIs) in obsessive-compulsive disorder (OCD) is an area of clinical interest, particularly for treatment-resistant cases. Standard SSRI doses often provide insufficient symptom relief, prompting clinicians to explore higher-than-recommended doses. Evidence suggests that supratherapeutic dosing can enhance serotonergic activity, potentially improving treatment response.
View Article and Find Full Text PDFCardiac Rehabilitation in Patients with Coronary Heart Disease - Provision, Attendance, and Outcomes: Results from the INTERASPIRE Survey from Fourteen Countries Across Six WHO Regions.
Glob Heart
September 2025
Department of Public Health and Primary Care, Ghent University, Belgium.
Background: INTERASPIRE was an observational study of patients with coronary heart disease (CHD) from 88 hospitals in 14 countries across all six WHO regions. The objective was to describe the proportions of patients referred to and attending cardiac rehabilitation (CR) programmes and to compare lifestyle and risk factor target achievement according to participation in a CR programme.
Methods: Patients 18-80 years of age, with a first or recurrent coronary hospitalisation (acute coronary syndrome and/or revascularisation procedure) were identified and invited to an interview and examination, between six months and two years after the index hospitalisation.